• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.67% Nasdaq Up 0.27%

    Incyte Corporation (INCY)

    -NasdaqGS
    75.67 Down 1.19(1.55%) 3:13PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:76.86
    Open:76.10
    Bid:75.36 x 100
    Ask:75.42 x 200
    1y Target Est:81.54
    Beta:0.17
    Earnings Date:Feb 10 - Feb 16 (Est.)
    Day's Range:74.56 - 77.25
    52wk Range:40.30 - 80.78
    Volume:749,090
    Avg Vol (3m):1,345,700
    Market Cap:12.78B
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYDown 1.55%12.78B
    AMGNDown 3.38%125.07B
    CELGDown 3.33%90.48B
    RHHBYUp 0.68%235.82B

    Key Statistics

    Forward P/E (1 yr):342.68
    P/S (ttm):26.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.13
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-7.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback